J Surg Tech Proced | Volume 7, Issue 2 | Case Report | Open Access

Severe Endometriosis with Intestinal Invasion: A Case Report and Literature Review

Carranco RC1*, Rivero MXV2 , Torres MFL2 , Alverde MJB2 , Gonzalez MFB2 , Salazar FE2 , Nehmad SS2 , Gascón JRC2 and Kondo W1

1Department of Pelvic Surgery, Doyenne High Quality and Multidisciplinary Treatment Center for Endometriosis, Mexico 2Center for Research in Health Sciences (CICSA), Universidad Anáhuac México Norte, Mexico

*Correspondance to: Ramiro Cabrera Carranco 

Fulltext PDF


Endometriosis is a pelvic inflammatory disease characterized by the growth of endometrial tissue outside the uterine cavity. The incidence is 10% to 15% and is present in over 50% of women experiencing chronic pelvic pain or infertility. The most common symptoms reported by patients include pelvic pain, dysmenorrhea, dyspareunia, abdominal pain, menstrual disorders, diarrhea or constipation, and infertility. The diagnosis of endometriosis is primarily clinical and supported by imaging studies, including transvaginal ultrasound, hysterosalpingography, and Magnetic Resonance Imaging (MRI). Treatment strategies typically involve pharmacological and hormonal approaches for mild stages, whereas more severe stages often necessitate surgical interventions. Conservative surgery is aimed at removing endometriotic lesions while preserving reproductive function. A case report is presented of a 38-year-old patient with endometriosis and intestinal invasion. Initially, she was solely treated for symptoms of menstrual syndrome with the administration of nonsteroidal analgesics. However, due to the lack of improvement, a potential case of endometriosis was suspected, leading to the implementation of specific surgical procedures for treatment.


Endometriosis; Anastomosis Primaria; Dysmenorrhea; MRI


Carranco RC, Rivero MXV, Torres MFL, Alverde MJB, Gonzalez MFB, Salazar FE, et al. Severe Endometriosis with Intestinal Invasion: A Case Report and Literature Review. J Surg Tech Proced. 2023; 7(2): 1061..

Subscribe to Our Newsletter